ORCIPRENALINE

Orciprenaline is a bronchodilating agent, which acts on â2-adrenergic receptors.

Indications

Bronchial asthma, Chronic bronchitis, Pulmonary emphysema. Orciprenaline sulphate is also useful in sarcoidosis, silicosis, carcinoma of the lung and tuberculosis when bronchospasm contributes to the disability.

Dosage

Oral; syrup 2mg per ml. Dose to be individualized, Adult Dosage: 20 mg (10 mL) t.i.d. or q.i.d. Pediatric Dosage: Ages 4-12: 10 mg (5 mL) t.i.d, Above 12 years : 20 mg (10 mL) t.i.d.

Contra-Indications

HOCM, Cardiac arrhythmia.

Special Precautions

Paediatric: Data not sufficient. Pregnancy: Data not sufficient. Lactation: Data not sufficient. Elderly: No overall differences in safety or effectiveness have been observed between elderly and other adult patients.

Side Effects

Shakes, nervousness, headache, dizziness, rapid or irregular heart beats.

Drug Interactions

Epinephrine, monoamine oxidase inhibitors or tricyclic antidepressants.